Over 3 weeks since the Halt , only 1/2 of Ann, SP heading further South, SI ??????, page-112

There will always be someone who thinks they know what should have been done better.

But because of the need for balance in discussion and perspective, repetition is sometimes needed IMO. People come into the threads at different times, and not all have the continuity. It's not repetitive for them it's new. Many of them are looking to the mood of the threads or to pick up information or a perspective they don't otherwise have.

You let one group dominate with an focus on the SP, the supposed betrayals by the MSB management, with supposed risk and so rarely about the upside. So rarely is there real recognition of essential elements of biotechs, including long lead times, and where the high reward might be.  IMO the factors that make MSB unique are about the upside, and are to be distinguished from drugs which are indeed high risk.

Yes we do need to recall that MSB is engaged in JV discussions with Celgene. Boring but true. And that there may be a number of reasons why MSB might not be able to disclose what is going on, or what is the background to the funding.

Personal attacks? Yes it has been rough in here. What can you do? It's ok to plug away trying to give a perspective that's missing on the face of the discussion.

The point of a dialectic is to reach the truth.

So you have a thread with multiple question marks?...possibly overreach IMO, but never mind. The SP seems to have stabilised for instance.

signed

Ms Congeniality.